Search

The addition of Ca2MgSi2O7 to CaSiO3 bioceramics was investigated in order to modify the dissolution rate of CaSiO3. A series of CaSiO3–xCa2MgSi2O7 composite ceramics with x values of 2, 5, 10, and 20 wt% have been successfully obtained. The effects of Ca2MgSi2O7 addition on CaSiO3–Ca2MgSi2O7 ceramics degradation behavior and apatite formation were comprehensively investigated by means of X-ray diffraction (XRD), scanning electron microscopy/energy-dispersive X-ray spectroscopy (SEM/EDS), Fourier transform infrared spectroscopy (FTIR), and inductively coupled plasma optical emission spectrometry (ICP-OES). The results showed that the dissolution rate of the achieve system ceramics gradually decreased in succession, and the apatite-forming was delayed by the addition of Ca2MgSi2O7. The suitable dissolution rate and apatite-forming ability of CaSiO3–Ca2MgSi2O7 bioceramics can be expected, indicating that the addition of Ca2MgSi2O7 to CaSiO3 bioceramics may be a promising route for modifying the dissolution behavior and apatite-forming ability of CaSiO3 bioceramics. [ABSTRACT FROM AUTHOR]

The high degradation rate limits the clinical applications of calcium silicate bioceramics. In this paper, Ca2MgSi2O7 and Ca2ZnSi2O7 were successfully prepared using sol-gel method by incorporating magnesium and zinc into Ca–Si-based system. The results showed that the obtained ceramics presented the macroporous structure and the incorporation of zinc obviously reduced the samples specific surface area. Compared with CaSiO3 (24.8%), the weight loss of Ca2ZnSi2O7 was the lowest (8.4%) and Ca2MgSi2O7 was the middle (12.1%) after 28 days soaking in Tris-HCl buffers. Meanwhile, the formation of apatite was also confirmed after soaking in SBF. Through above investigations, the incorporation of magnesium and zinc should be one of the effective ways to adjust the degradation and apatite formation of Ca–Si-based bioceramics, which would meet the various clinical demands. [ABSTRACT FROM AUTHOR]